LCG
CNMD icon

Lisanti Capital Growth’s CONMED CNMD Stock Holding History

Lisanti Capital Growth’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,570
Closed -$4.44M – 123
2023
Q4 		$4.44M Buy
+40,570
New +$4.19M 1.05% 39
2023
Q3 		– Sell
-15,885
Closed -$2.16M – 126
2023
Q2 		$2.16M Buy
+15,885
New +$1.94M 0.3% 110

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Lisanti Capital Growth's CNMD Position: Q1 2024 in Review

Lisanti Capital Growth sold out of CONMED (CNMD) in Q1 2024, closing a stake of 40,570 shares — an estimated $4.44M sold.

Lisanti Capital Growth first reported a position in CNMD in Q2 2023 and held it in 2 quarters. The position peaked at $4.44M in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Lisanti Capital Growth reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 40,570 CONMED shares in Q1 2024, an estimated $4.44M.
  • Lisanti Capital Growth first reported a position in CONMED in Q2 2023 and held it in 2 quarters.
  • Lisanti Capital Growth's CONMED position peaked at $4.44M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Lisanti Capital Growth's 13F filing for Q1 2024, filed 7 May 2024.